Company description

Galenica is one of the largest Greek pharmaceutical companies which promotes research and serves health with consistency and scientific responsibility, by developing high-quality and innovative pharmaceutical products. Founded in 1974 by the pharmacists Denis Varelas and Basile Tamvacas, it became very soon one of the most dynamic companies in the sector with impressive rates of growth and development. It is the first Greek company that focused on the acquisition of know how and marketing of ethical products, through the cooperation with well established foreign research based pharmaceutical companies. Galenica has  a strong in-licensed product portfolio sold mainly in Greece,  Cyprus, Romania, Bulgaria and is focusing in development of new dosage forms of known compounds  and products of natural origin for out –licensing. Since the last years, the company invests on the field of biotechnology, realizing the important role that this science plays in the discovery of new methods, both for the treatment and the prevention of diseases.

Quick facts

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Affiliated categories: Capsules |Plant Extracts |Finished Dosage Forms More

Recently at

5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany We were at stand 80D50 See our Exhibitor Profile   See full Exhibitor List

Categories affiliated with Galenica S.A

Galenica S.A

Contact information




View all contact information